Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Int Immunopharmacol ; 43: 40-52, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27939824

ABSTRACT

Intravenously injected lipopolysaccharides (LPS) rapidly induce pulmonary platelet accumulation (PPA) and anaphylaxis-like shock (ALS) in mice. Macrophages reportedly release catecholamines rapidly upon stimulation with LPS. Here, we examined the involvement of macrophage-derived catecholamines in LPS-induced PPA and ALS. A catecholamine or Klebsiella O3 (KO3) LPS was intravenously injected into mice, with 5-hydroxytryptamine in the lung being measured as a platelet marker. The tested catecholamines induced PPA, leading to shock. Their minimum shock-inducing doses were at the nmol/kg level. The effects of epinephrine and norepinephrine were inhibited by prazosin (α1 antagonist) and by yohimbine (α2 antagonist), while dopamine's were inhibited only by prazosin. Use of synthetic adrenergic α1- and/or α2-agonists, platelet- or macrophage-depleted mice, a complement C5 inhibitor and C5-deficient mice revealed that (a) α2-receptor-mediated PPA and shock depend on both macrophages and complements, while α1-receptor-mediated PPA and shock depend on neither macrophages nor complements, (b) the PPA and ALS induced by KO3-LPS depend on α1- and α2-receptors, macrophages, and complements, and (c) KO3-LPS-induced PPA is preceded by catecholamines decreasing in serum. Together, these results suggest the following. (i) Catecholamines may stimulate macrophages and release complement C5 via α2-receptors. (ii) Macrophage-derived catecholamines may mediate LPS-induced PPA and ALS. (iii) Moderate PPA may serve as a defense mechanism to remove excess catecholamines from the circulation by promoting their rapid uptake, thus preventing excessive systemic effects. (iv) The present findings might provide an insight into possible future pharmacological strategies against such diseases as shock and acute respiratory distress syndrome.


Subject(s)
Anaphylaxis/drug therapy , Blood Platelets/drug effects , Catecholamines/pharmacology , Lung/pathology , Macrophages/drug effects , Respiratory Distress Syndrome/drug therapy , Anaphylaxis/chemically induced , Animals , Blood Platelets/physiology , Cells, Cultured , Complement C5/genetics , Complement C5/metabolism , Humans , Lipopolysaccharides/immunology , Lung/drug effects , Macrophages/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Prazosin/pharmacology , Serotonin/metabolism , Yohimbine/pharmacology
2.
Neurochem Int ; 63(4): 309-15, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23871718

ABSTRACT

It is well known that the characteristics of mastication are important for the maintenance of our physical well-being. In this study, to assess the importance of the effects of food hardness during mastication, we investigated whether a long-term powdered diet might cause changes in emotional behavior tests, including spontaneous locomotor activity and social interaction (SI) tests, and the dopaminergic system of the frontal cortex and hippocampus in mice. Mice fed a powdered diet for 17 weeks from weaning were compared with mice fed a standard diet (control). The dopamine turnover and expression of dopamine receptors mRNA in the frontal cortex were also evaluated. Spontaneous locomotor activity, SI time and dopamine turnover of the frontal cortex were increased in powdered diet-fed mice. On the other hand, the expression of dopamine-4 (D4) receptors mRNA in the frontal cortex was decreased in powdered diet-fed mice. Moreover, we examined the effect of PD168077, a selective D4 agonist, on the increased SI time in powdered diet-fed mice. Treatment with PD168077 decreased the SI time. These results suggest that the masticatory dysfunction induced by long-term powdered diet feeding may cause the increased SI time and the changes in the dopaminergic system, especially dopamine D4 receptor subtype in the frontal cortex.


Subject(s)
Diet , Dopamine/metabolism , Interpersonal Relations , Animal Feed , Animals , Base Sequence , Benzamides/pharmacology , DNA Primers , Dopamine Agonists/pharmacology , Hippocampus/metabolism , Male , Mice , Mice, Inbred BALB C , Piperazines/pharmacology , Powders , RNA, Messenger/genetics , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Receptors, Dopamine/drug effects , Receptors, Dopamine/genetics , Receptors, Dopamine/metabolism
3.
Biol Pharm Bull ; 33(4): 617-21, 2010.
Article in English | MEDLINE | ID: mdl-20410595

ABSTRACT

An imbalance between noradrenergic and dopaminergic systems is implicated in hyperactivity disorders, such as attention deficit/hyperactivity disorder (ADHD). We previously showed that the explosive jumping behavior elicited by intermittent rapid eye movement sleep deprivation (REMSD) may serve as a useful model of ADHD (see [Biogenic Amines, 20, 99-111]). Here, we investigated whether intermittent REMSD might cause changes in monoamine turnover in the mouse forebrain. Our main findings were as follows. Intermittent REMSD led to a significant decrease in dopamine turnover and a significant increase in noradrenaline turnover in the frontal cortex. The latter effect, but not the former, was attenuated by atomoxetine, which is used clinically to treat ADHD symptoms. These results suggest (a) that intermittent REMSD induces hypernoradrenergic and hypodopaminergic states within the frontal cortex, and (b) that the therapeutic effects of atomoxetine may include an inhibition of this hypernoradrenergic state.


Subject(s)
Adrenergic Uptake Inhibitors/pharmacology , Dopamine/metabolism , Frontal Lobe/metabolism , Hyperkinesis/drug therapy , Norepinephrine/metabolism , Propylamines/pharmacology , Sleep Deprivation/complications , Adrenergic Uptake Inhibitors/therapeutic use , Animals , Atomoxetine Hydrochloride , Attention Deficit Disorder with Hyperactivity/drug therapy , Behavior, Animal/drug effects , Disease Models, Animal , Frontal Lobe/drug effects , Hyperkinesis/etiology , Hyperkinesis/metabolism , Male , Mice , Mice, Inbred Strains , Movement , Propylamines/therapeutic use , Sleep Deprivation/metabolism , Sleep, REM/physiology
4.
Behav Brain Res ; 208(1): 224-30, 2010 Mar 17.
Article in English | MEDLINE | ID: mdl-19963013

ABSTRACT

N-type voltage-dependent calcium channels (VDCCs) play an important role in neurotransmission, synaptic plasticity, and brain development. They are composed of several subunits named alpha(1), alpha(2), delta, beta and gamma. The alpha(1) subunit is essential for channel functions and determines fundamental channel properties. Since N-type VDCC are critically involved in the release of neurotransmitters and clinical relevance, we predicted that alpha(1) subunit KO mice would show several alterations in behavior. In the present study, we investigated neuronal functions in mice lacking the alpha(1B) (Ca(V)2.2) subunit of the N-type calcium channels. Ca(V)2.2(-/-) mice exhibited a significant increase in locomotion on an activity wheel during the dark phase. Furthermore, when challenged with apomorphine, mutant mice showed enhanced locomotor activity. Cognitive functions were examined using a Y-maze task for short-term memory and a passive avoidance task for long-term memory. The Y-maze revealed no differences in spontaneous alternation behavior between mutant and wild-type mice. The passive avoidance test revealed that the latency time in mutant mice was significantly decreased. The mutant mice showed prepulse inhibition deficits reminiscent of the sensorimotor gating deficits observed in a large majority of schizophrenic patients. Decreases in baseline levels of dopamine and serotonin within the striata and frontal cortices of mutant mice were also observed. These results suggest that Ca(2+) in the central nervous system modulates various neurophysiological functions, such as locomotor activity, long-term memory, and sensorimotor gating through the alpha(1B) subunit of the N-type calcium channels.


Subject(s)
Behavior, Animal/physiology , Biogenic Monoamines/metabolism , Brain/metabolism , Calcium Channels, N-Type/deficiency , Acoustic Stimulation/methods , Analysis of Variance , Animals , Apomorphine/pharmacology , Avoidance Learning/drug effects , Avoidance Learning/physiology , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid/methods , Circadian Rhythm/genetics , Dopamine Agonists/pharmacology , Exploratory Behavior/physiology , Inhibition, Psychological , Locomotion/drug effects , Locomotion/genetics , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Reaction Time/drug effects , Reaction Time/genetics , Reflex, Startle/drug effects , Reflex, Startle/genetics , Rotarod Performance Test/methods
5.
J Pharmacol Toxicol Methods ; 50(3): 223-9, 2004.
Article in English | MEDLINE | ID: mdl-15519909

ABSTRACT

INTRODUCTION: To measure levels of phosphatidylcholine (PtdCh) in various mouse tissues, we developed a rapid and precise method using high-performance liquid chromatography (HPLC) with electrochemical detection (ECD) and an immobilized enzyme column. To generate an example data set, the effect of methoxamine (an alpha1-adrenergic agonist) on the PtdCh levels was examined by this method in the artery and the submandibular gland of the mouse in vivo. METHODS: Under our modifications of the method of Zapata et al. [J. Neurosci. 18 (1998) 3597], the mixture of lipophilic choline metabolites (PtdCh, lyso-PtdCh, and sphingomyelin) extracted by chloroform from the tissue homogenate was dried without prior separation and hydrolyzed with free choline by a 1-N perchloric acid solution containing ethylhomocholine (an internal standard for choline assay) at 90 degrees C for 1 h. Subsequently, the hydrolyzed mixture was injected directly into the HPLC system for PtdCh assay. RESULTS: The present method permitted PtdCh assay within 5 min in one chromatographic run. Recovery of an authentic PtdCh sample was 99% (n = 10). The within-run coefficients of variation for choline derived from PtdCh in the same tissue samples were 0.6% (n = 10) and 1.3% (n = 30). Under the present method, the lowest and highest PtdCh values in tissue samples were about 2 micromol/g (eye ball) and 29 micromol/g (spinal cord), respectively. Methoxamine significantly decreased PtdCh levels and increased free choline levels in mouse artery and submandibular gland. DISCUSSION: Under the present sample processing procedure, the choline values originating from lyso-PtdCh and sphingomyelin were much less than those originating from PtdCh hydrolysis. Thus, it was possible to inject the hydrolyzed mixture directly into the HPLC system for PtdCh assay. Since the present method provides simple, rapid, and highly reliable PtdCh determination, it is suitable for routine assay of PtdCh in a large number of samples.


Subject(s)
Biological Assay/methods , Chromatography, High Pressure Liquid/methods , Electrochemistry/methods , Phosphatidylcholines/analysis , Adrenergic alpha-Agonists/pharmacokinetics , Animals , Chromatography, High Pressure Liquid/instrumentation , Enzymes, Immobilized , Methoxamine/pharmacokinetics , Mice , Reproducibility of Results , Submandibular Gland/metabolism , Tissue Distribution
6.
Genes Genet Syst ; 79(3): 129-37, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15329493

ABSTRACT

The flanking region of the antigen I/II gene, paaA, in Streptococcus cricetus was examined using the gene-walking technique. In the region downstream of the paaA gene, another antigen I/II gene designated as paaB was found. The paaB gene was disrupted at the alanine-rich region (A region) by a novel insertion sequence element, ISScr1. ISScr1 is a member of the IS982 family and is composed of a 962-bp sequence and duplicated target DNA (the sequence 5'-TAGCTAAAT-3') resulting from its insertion. To clarify the structural divergence of the two antigen I/II proteins (PAaA and PAaB), computational analysis of the paaB gene was performed and the two structures were compared. The amino acid sequence homology indicated that PAaB resembled PAaA, but the middle region showed little similarity to that of PAaA. Phylogenetic analysis showed that PAaB was better classified in a major group with S. mutans PAc and S. gordonii SspA and SspB than with PAaA. The transcriptional expression of paaA and paaB was demonstrated by reverse transcription (RT)-PCR. In the region upstream of the paaA gene, three genes homologous to the genes located in the region upstream of the S. sobrinus antigen I/II gene (pag) were found. Of the three genes, ORF3 showed homology to the par gene encoding a transcriptional repressor for the pag gene in S. sobrinus. Therefore, ORF3 was designated the par gene of S. cricetus. Southern hybridization revealed that the par gene of S. cricetus was not found in other oral streptococci examined in this study.


Subject(s)
Bacterial Proteins/genetics , Genes, Regulator , Membrane Glycoproteins/genetics , Streptococcus/genetics , Amino Acid Sequence , Bacterial Proteins/metabolism , Cloning, Molecular , DNA Transposable Elements , DNA, Intergenic , Gene Expression Regulation, Bacterial , Membrane Glycoproteins/metabolism , Molecular Sequence Data , Open Reading Frames , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Streptococcus/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL